Efstathios S. Avgoustiniatos

Efstathios S. Avgoustiniatos

Auto-generated profile, based on publicly available information

Efstathios S. Avgoustiniatos

Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2016 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
TSThomas M. Suszynski
Thomas M. Suszynski
EAEfstathios S. Avgoustiniatos
Efstathios S. Avgoustiniatos
KPKlearchos K PAPAS
Klearchos K PAPAS
Intraportal islet transplantation (IT) is not widely utilized as a treatment for type 1 diabetes. Oxygenation of the intraportally transplanted islet has not been studied extensively. We present a diffusion-reaction model that predicts the presence of ananoxiccore and a largerpartly functionalcore within intraportally transplanted islets. Four variables were studied: islet diameter, islet fractional viability, external oxygen partial pressure (P) (in surrounding portal blood), and presence or absence of a thrombus on the islet surface. Results indicate that an islet with average size and fractional viability exhibits an anoxic volume fraction (AVF) of 14% and a function loss of 72% at a low externalP. Thrombus formation increased AVF to 30% and function loss to 92%, suggesting that the effect of thrombosis may be substantial. ExternalPand islet diameter accounted for the greatest overall impact on AVF and loss of function. At our institutions, large human alloislets (>200μm diameter) account for ~20% of total islet number but ~70% of total islet volume; since most of the total transplanted islet volume is accounted for by large islets, most of the intraportal islet cells are likely to be anoxic and not fully functional.